This degeneration may be linked to reduced GLO1 activity, which has also been observed in some patients with Parkinson’s disease (PD), schizophrenia, and amyotrophic lateral sclerosis (ALS) [343]. This evidence concerns the gene GLO1 and Parkinson disease.